Top Markets
Coin of the day
DermTech, Inc. DermTech, Inc.

DermTech, Inc.

DMTK
Clasificación en acciones #37065
DermTech, Inc., a molecular diagnostics firm headquartered in La Jolla,... DermTech, Inc., a molecular diagnostics firm headquartered in La Jolla, California, specializes in creating and bringing to market advanced, non-invasive genomic tests. Operating within the United States, their innovative solutions facilitate the diagnosis of various dermatological issues, including skin cancer, inflammatory conditions, and age-related skin concerns. A cornerstone of their offerings is the DermTech Melanoma Test (DMT), a sophisticated gene expression analysis. This assay plays a crucial role in enhancing the early identification of genomic abnormalities, effectively aiding in the exclusion of melanoma and often removing the need for invasive surgical biopsies of suspicious pigmented lesions. The company further provides specialized adhesive kits for convenient skin sample collection. Additionally, they offer gene expression assays designed to analyze key inflammatory pathways such, as Th1, Th2, IFN-gamma, and Th17. Looking ahead, DermTech is actively developing a pipeline of new products, which includes DNA risk assessment tools for UV damage, diagnostic tests for non-melanoma skin cancers, and rule-out tests for cutaneous T-cell lymphoma. They also extend their services by delivering health-related information and support through digital and telecommunication platforms. DermTech's diagnostic products and services are primarily targeted towards medical professionals in the fields of pathology and oncology.
Precio por acción
$0.069
Última sincronización: 2024-07-22
Capitalización bursátil
$2.06M
Cambio (1 día)
-1.43%
Cambio (1 año)
0.00%
País
US
Comercio DermTech, Inc. (DMTK)

Categoría

EPS de DermTech, Inc. (DMTK)
EPS a fecha de March 2024 TTM: $-2.70
Según los últimos informes financieros y el precio de las acciones de DermTech, Inc., el EPS actual de la empresa (TTM) es $-2.70. Al final del año 2022, la empresa tenía un EPS de $-3.88 un aumento con respecto a al EPS de 2021, que fue de $-2.71.
Historial de EPS de DermTech, Inc. desde 2012 hasta 2026
EPS al final de cada año
Año EPS Cambiar
2026 (TTM) $-2.70 -12.62%
2023 $-3.09 -20.36%
2022 $-3.88 43.17%
2021 $-2.71 32.20%
2020 $-2.05 -34.50%
2019 $-3.13 -969.44%
2018 $0.36 0.00%
2017 0.00 -100.00%
2013 $-1.10 69.23%
2012 $-0.65 0.00%
EPS de empresas similares o competidoras
Empresa EPS Diferencia de EPS País
$18.62 -789.63%
US
$5.65 -309.26%
US
- -
CN
$-1.36 -49.63%
US
$14.24 -627.41%
US